All seven participants in a small Phase 2 trial experienced clinically meaningful improvements, and six remained off immunosuppressants at their latest follow-up: https://bit.ly/4ykYMT8

#MyastheniaGravis #MGFA #CARTCellTherapy #MyastheniaGravisNews #Bionews